Pfizer Inc [NYSE: PFE] stock went on an upward path that rose over 63098136% on Friday, amounting to a one-week price decrease of less than -3.50%.
Over the last 12 months, PFE stock dropped by -9.65%. The one-year Pfizer Inc stock forecast points to a potential downside of -188758348.95. The average equity rating for PFE stock is currently 2.44, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $136.28 billion, with 5.68 billion shares outstanding and 5.67 billion shares in the current float. Compared to the average trading volume of 53.06M shares, PFE stock reached a trading volume of 63098136 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Pfizer Inc [PFE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $28.11 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Pfizer Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 22, 2025. While these analysts kept the previous recommendation, BofA Securities raised their target price to Neutral. The new note on the price target was released on December 10, 2024, representing the official price target for Pfizer Inc stock. Previously, the target price had yet another raise to $25, while Wolfe Research analysts kept a Underperform rating on PFE stock.
The Price to Book ratio for the last quarter was 1.51, with the Price to Cash per share for the same quarter was set at 3.05. Price to Free Cash Flow for PFE in the course of the last twelve months was 12.15 with Quick ratio for the last quarter at 0.96.
PFE Stock Performance Analysis:
Pfizer Inc [PFE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.50. With this latest performance, PFE shares gained by 1.91% in over the last four-week period, additionally sinking by -5.07% over the last 6 months – not to mention a drop of -9.65% in the past year of trading.
Insight into Pfizer Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Pfizer Inc [PFE] shares currently have an operating margin of 27.53% and a Gross Margin at 66.93%. Pfizer Inc’s Net Margin is presently recorded at 12.59%.
Return on Equity for this stock inclined to 3.67%, with Return on Assets sitting at 3.67%.
PFE Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc go to -0.27%.
Pfizer Inc [PFE] Institutonal Ownership Details
There are presently around $67.59%, or 67.63%% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 511.4 million shares, which is approximately 9.0258%. BLACKROCK INC., holding 424.38 million shares of the stock with an approximate value of $$11.87 billion in PFE stocks shares; and BLACKROCK INC., currently with $$8.03 billion in PFE stock with ownership which is approximately 5.0663%.
